Evidence mapPaperPMID 40900592Full record

Trial reportJAMA network open2025

Functional Connectivity Predicting Transdiagnostic Treatment Outcomes in Internalizing Psychopathologies.

Kai Zhang, Heide Klumpp, Jagan Jimmy, K Luan Phan, Mohammed R Milad, Zhenfu Wen

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kai ZhangFaillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston.
Heide KlumppDepartment of Psychiatry, University of Illinois Chicago, Chicago.
Jagan JimmyDepartment of Psychiatry and Behavioral Health, The Ohio State University, Columbus.
K Luan PhanDepartment of Psychiatry and Behavioral Health, The Ohio State University, Columbus.
Mohammed R MiladFaillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston.
Zhenfu WenFaillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Predicting treatment outcomes for internalizing psychopathologies (IPs), such as depression and anxiety, holds promise for advancing precision medicine. The extent to which whole-brain functional connectivity (FC) can predict treatment responses for patients with IPs across different therapeutic modalities remains unclear. Objective: To examine whether pretreatment FC patterns predict multidimensional treatment outcomes in patients with IPs and whether predictive performance generalizes across diagnoses and treatment modalities. Design, Setting, and Participants: This prognostic study analyzed baseline neuroimaging and clinical data from patients with IPs enrolled in 1 of 2 randomized clinical trials (conducted from December 2013 to February 2018 and September 2017 to December 2020). Data analysis for predictive modeling was conducted from September 2024 through March 2025. Exposures: Participants were randomized to receive 12 weeks of cognitive-behavioral therapy (CBT), selective-serotonin reuptake inhibitor (SSRI) treatment, or supportive therapy (ST). Main Outcomes and Measures: A regularized canonical correlation analysis model was trained with pretreatment FC patterns. The ability of the model to predict multidimensional treatment outcomes spanning depression, anxiety, worry, rumination, and emotion regulation was tested. The predictive model was evaluated across diagnostic categories and treatment modalities. Results: In 181 patients with IPs (mean [SD] age, 27.7 [9.2] years; 127 women [71%] and 52 men [29%]) randomized to receive CBT (n = 89), SSRI treatment (n = 46), or ST (n = 46), baseline whole-brain connectivity robustly predicted multidimensional symptom changes. Predictions were significant at the individual level (r = 0.37, P = .009, permutation test), across diagnoses (r = 0.24, P = .02) and across treatment modalities (ST: r = 0.28, P = .02; SSRI treatment: r = 0.39, P = .006; and CBT: r = 0.32, P = .003). Connections significantly contributing to the FC variate were distributed across the brain, but especially within the default mode network and the dorsal and ventral attention networks. Predictive performance decreased in models incorporating fewer neural systems or clinical outcome dimensions. Conclusions and Relevance: In this prognostic study assessing predictive models of 181 patients with IPs, whole-brain FC reliably predicted multidimensional treatment outcomes across diagnoses and treatment modalities. These results suggest an association between neural connectivity patterns within specific neural networks and clinical improvements induced by varying treatment modalities, thereby advancing efforts toward personalized treatment approaches in psychiatry.

Indexed as

AnxietyBrainCognitive Behavioral TherapyDepressionAdultFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedPrognosisSelective Serotonin Reuptake InhibitorsTreatment OutcomeSelective Serotonin Reuptake Inhibitors

Identifiers

PMID40900592
PMCPMC12409597

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.